)
SWK (SWKH) investor relations material
SWK Proxy Filing summary
Complete event summary combining all related documents: earnings call transcript, report, and slide presentation.Executive summary
A special meeting is scheduled for March 31, 2026, for shareholders to vote on a proposed merger between SWK Holdings Corporation and Runway Growth Finance Corp. (RWAY), with SWK merging into a wholly-owned RWAY subsidiary and ultimately becoming part of RWAY through a three-step merger process.
The merger consideration for SWK shareholders includes a choice between cash or RWAY stock (subject to proration), plus a guaranteed $9 million cash payment from RWAY's adviser, with the exchange ratio based on net asset values determined shortly before closing.
The SWK board unanimously recommends voting in favor of the merger and related proposals, citing a robust strategic review process, premium to standalone price, and anticipated benefits such as increased scale, diversification, and improved access to capital.
The merger is expected to be accretive to RWAY's net investment income, with pro forma financials showing increased assets, diversified investments, and projected cost savings from eliminating duplicative expenses.
The transaction is structured as an asset acquisition for accounting purposes, with no goodwill recognized, and is expected to be taxable for SWK shareholders.
Voting matters and shareholder proposals
Shareholders will vote on four proposals: (1) approval of the merger agreement, (2) non-binding advisory approval of executive compensation related to the merger, (3) approval of director compensation related to the merger, and (4) approval of adjournment if more time is needed to solicit votes.
Approval of the merger requires a majority of outstanding SWK shares; compensation and adjournment proposals require a majority of votes cast.
Appraisal rights are available to dissenting SWK shareholders under Delaware law.
Board of directors and corporate governance
The RWAY board will remain unchanged post-merger, and RWAY's adviser will continue to manage the combined company.
SWK's board is composed solely of independent directors, and a key stockholder agreement ensures the largest shareholder will vote in favor of the merger.
Next SWK earnings date
Next SWK earnings date
The essential earnings season companion
The #1 app for qualitative research. Live earnings calls, AI chat, transcripts, and more. All for free.
Live calls and transcripts
Listen to earnings calls, CMDs, investor conferences, and more – with a podcast-like experience.
Find what you need faster
Search for any keyword across all transcripts simultaneously.
Easily store key findings
Capturing important takeaways is as simple as it gets. Even during your lunch run or commute.
Your watchlist. Your dashboard.
Follow the companies that matter to you. Get a personalized feed with real-time updates.
Be the first to know
Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned.
Consensus estimates
Access analyst consensus estimates, valuation multiples, and revenue segments splits.
All IR material in one place
The easiest way to stay updated during earnings season.
Global coverage
All events from public companies. Live and recorded.
Just click and listen
No webcast links. No manual registrations.
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
I can't remember the last time an app had such a positive impact on my investment process.
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
I can't remember the last time an app had such a positive impact on my investment process.
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
)
)
)
Frequently asked questions
At the Intersection of Finance and Healthcare
SWK Holdings Corporation is an American finance company that primarily operates within the healthcare sector, with a focus on life sciences and pharmaceuticals. Given the capital-intensive nature of healthcare innovations, SWK Holdings provides financial support and investments to initiatives in the sector. The company offers customized financing solutions tailored to support companies in various stages of research, development, and commercialization.
Texas Made
SWK Holdings was founded in 1996 and is headquartered in Dallas, Texas. The company operates in two different segments: Life Science Specialty Finance and Enteris BioPharma, which are both centered on SWK’s core focus on monetizing revenue streams and intellectual property within the life sciences sector. The company's approach is centered on understanding the specific needs of healthcare and biotech enterprises, offering financial structures that facilitate growth and advancement. Given the complex nature of the industry, having the right expertise and experience is absolutely paramount to achieving the best possible results. Some companies that SWK has worked closely with include Aziyo, Biolase, and Eton Pharmaceuticals.
Life Science Specialty Finance
Recognizing the unique financial challenges companies in life sciences face, particularly when it comes to drug development and medical innovation, SWK provides tailored financing solutions. These are designed to address the capital-intensive nature of research, clinical trials, and product commercialization. Through its specialty finance operations, SWK extends secured loans to smaller life science companies, bridging funding gaps and ensuring the continuity of research. In return, SWK typically benefits from interest and fees, as well as royalties from successfully commercialized products.
Enteris BioPharma
Enteris BioPharma, a subsidiary of SWK Holdings, is a biotechnology company specializing in developing innovative drug delivery solutions. One of its core technologies is the Peptelligence™ platform, which enables oral delivery of molecules that are traditionally administered through injections.
Mobile app: Research anytime, anywhere with the #1 app for live earnings calls, transcripts, analyst estimates, and more. All for free.
Desktop (Quartr Pro): The leading platform for qualitative research, used daily by top firms and financial institutions.
Quartr API: Build custom solutions powered by live earnings calls, live transcripts, filings and reports, slide presentations, and more.
Explore our global coverage